Citius Pharmaceuticals, Inc. - Common Stock (NQ:CTXR)
All News about Citius Pharmaceuticals, Inc. - Common Stock
Citius Pharmaceuticals (NASDAQ: CTXR) Eyes $400M Market Opportunity with LYMPHIR Launch
Today 7:01 EDT
Via AB Newswire
Topics
Economy
Citius Posts Wider Loss in Fiscal Q3
August 13, 2025
Via The Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.